Ingredient
Myristamide Dipa
Myristamide Dipa is flagged for pregnancy, trying to conceive and PCOS. The concern behind the strongest flag is endocrine disruptor and absorbed into the body.
- Myristamide DEA
- N,N-Bis(2-hydroxyethyl)myristamide
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 3 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Myristamide Dipa and pregnancy
Caution Advised
- Endocrine disruptor
- Absorbed into the body
Myristamide DIPA is a surfactant and cleansing agent derived from diethanolamine (DEA), used to create foam and lather in personal care products. It functions by reducing surface tension, allowing water and oil to mix for effective cleansing. While specific pregnancy studies on myristamide DIPA are limited, concerns arise from its DEA-based structure. Some animal studies on DEA compounds have shown potential developmental effects and hormonal disruption, though direct human evidence is lacking. The ingredient can be absorbed through the skin, raising theoretical concerns about fetal exposure. Most obstetricians suggest a precautionary approach with DEA derivatives during pregnancy, particularly in products used frequently or left on the skin. The EU restricts DEA and its derivatives in cosmetics, requiring finished products contain no more than 0.5% DEA. While there's no absolute prohibition for pregnancy, many women choose to minimize exposure to DEA-based ingredients during gestation due to uncertainty about developmental effects. Consider switching to DEA-free cleansers during pregnancy if concerned.
Myristamide Dipa and breastfeeding
Safe to Use
- Passes into breast milk
Myristamide DIPA is a surfactant used in cleansing products. During breastfeeding, the primary consideration is whether the ingredient can transfer to breast milk and affect the breastfed infant. Studies specifically examining myristamide DIPA transfer to breast milk are not available. However, the ingredient is typically used in rinse-off products like shampoos and body washes, which limits skin contact time and absorption. DEA compounds can be absorbed systemically, but the amounts from topical cosmetic use are generally considered low. Most dermatologists view rinse-off DEA derivatives as lower concern during breastfeeding compared to pregnancy. There are no specific medical guidelines prohibiting use during breastfeeding. If using products containing this ingredient, ensuring thorough rinsing and avoiding breast area application before breastfeeding can minimize any theoretical infant exposure. For maximum caution, DEA-free alternatives are available.
Myristamide Dipa and postpartum
Safe to Use
- Irritant
For postpartum women who are not breastfeeding, myristamide DIPA presents minimal concerns beyond general skin irritation potential. The ingredient functions as an effective surfactant in cleansing products. The main consideration is skin sensitivity, which can be heightened postpartum due to hormonal changes. Some individuals may experience mild irritation or dryness from DEA-derived surfactants. However, there are no reproductive or hormonal concerns for non-breastfeeding postpartum women using products with this ingredient in typical cosmetic concentrations.
Myristamide Dipa and trying to conceive
Caution Advised
- Hormone disruptor
- Fertility effects
For women trying to conceive, the precautionary principle suggests minimizing exposure to potential endocrine disruptors. Myristamide DIPA, as a DEA derivative, falls into this category of theoretical concern. While there's no direct evidence that cosmetic use of myristamide DIPA affects fertility, some animal studies on DEA compounds have shown hormonal effects. Many fertility specialists recommend reducing exposure to questionable ingredients during the conception period. Since effective alternatives exist, switching to DEA-free cleansers is a reasonable precautionary measure when trying to conceive.
Myristamide Dipa and PCOS
Caution Advised
- Interferes with hormones
Myristamide DIPA is a surfactant used in cleansing products. For women with PCOS, the theoretical concern relates to potential endocrine-disrupting properties of DEA derivatives. While direct studies on myristamide DIPA and PCOS are lacking, some research suggests DEA compounds may have weak estrogenic or anti-androgenic activity. For women with PCOS who already experience hormonal imbalances, some practitioners recommend minimizing exposure to potential endocrine disruptors. However, the evidence is not conclusive, and the ingredient is used in rinse-off products that limit absorption. There are no absolute contraindications for PCOS patients using products with this ingredient. If concerned about hormonal effects, choosing surfactant alternatives like glucosides or isethionates may provide peace of mind. Focus on ingredients that support skin barrier function and manage PCOS-related skin concerns like acne.
Myristamide Dipa and general use
Safe to Use
- Irritant
For the general population, myristamide DIPA is considered a low-risk ingredient when used in cosmetic products at regulated concentrations. It effectively creates foam and enhances cleansing properties in personal care products. The primary concern for most users is potential skin irritation, which can occur in sensitive individuals. DEA derivatives may cause dryness or mild irritation with prolonged exposure. The EU has established concentration limits to minimize potential nitrosamine formation, a regulatory measure that addresses long-term safety concerns. For most people without specific health conditions, occasional use of products containing this ingredient is not problematic. Those with sensitive skin may prefer gentler surfactant alternatives. Rinse-off products pose less concern than leave-on formulations due to reduced skin contact time.
Everything else flagged for the same profiles
Related ingredients
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store